Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia.
D006689:Hodgkin Disease / Q000628:therapy*; D007938:Leukemia / Q000628:therapy*; D008466:Mechlorethamine; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*
D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine
HODGKIN'S DISEASE/therapy; LEUKEMIA/therapy; NITROGEN MUSTARDS/therapeutic use
Indication de l'utilisation de la beta-naphtyl-di-2-chloroethylamine, dans la maladie de Hodgkin et la Leucemie.